Curis, Inc., a biotechnology company, focuses on the development and commercialization of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include CUDC-907, an oral dual inhibitor of HDAC and PI3K enzymes, which is in Phase II clinical trial for the treatment of patients with MYC-altered diffuse […]
Read MoreVirtu Financial, Inc., together with its subsidiaries, provides market making and liquidity services through its proprietary, multi-asset, and multi-currency technology platform to the financial markets worldwide. The company’s Market Making segment principally consists of market making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Its Execution Services segment […]
Read MoreShares of the Boeing Co. (BA) are in a free fall this week as the defense company and jet maker reels from a devastating crisis over its newest commercial plane model. The company’s massive loss in market value has even dragged down the Dow Jones Industrial Average, of which Boeing is one of the largest […]
Read MoreYesterday I wrote about the biggest oil services and equipment provider in the United States. A lot of stocks in the energy sector, and oil specifically, have mostly underperformed the rest of the market this year, and I think that could provide an interesting opportunity for the attentive – and patient – investor. Because most […]
Read More